Skip to content

Effect of Cap-assisted Esophagogastroduodenoscopy on Observation of Major Duodenal Papilla

Effect of Cap-assisted Esophagogastroduodenoscopy on Observation of Major Duodenal Papilla: a Randomized Non-inferiority Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03219619
Enrollment
171
Registered
2017-07-17
Start date
2018-07-20
Completion date
2018-07-20
Last updated
2019-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Observation of Major Duodenal Papilla (MDP)

Brief summary

Examination of major duodenal papilla (MDP) using a side-viewing duodenoscope is a golden standard. However, side-viewing duodenoscope is not available in some endoscopic centers. Cap-assisted esophagogastroduodenoscopy (Ca-EGD) using a transparent cap fitted to the tip of the scope has emerged as an alternative method for the observation of MDP. A recent study showed that complete examination of MDP could be achieved in 97% of patients. The investigators hypothesize that Ca-EGD is non-inferior to duodenoscope for the observation of MDP.

Detailed description

Interim analyses were planned to be performed by the data and safety monitoring board after data collection has been completed for 50% of the enrollment.

Interventions

DEVICECap-EGD

Undergoing cap-assisted endoscopy

DEVICEDuo

Undergoing side-viewing duodenoscope

Sponsors

Air Force Military Medical University, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years and \< 70 years * Patients with native MDP who underwent ERCP

Exclusion criteria

* Prior surgery in upper GI tract * Prior history of endoscopic sphincterotomy * Prior history of MDP treatment * Known or suspected obstruction of upper GI tract * Patients in poor condition who may not be suitable for Ca-EGD or duodenoscope * Pregnancy or lactic women * Inability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Rate of complete examination of MDP5 minutes after intubation of the esophagusComplete examination is defined by visualization of both proximal and distal ends with orifice of papilla

Secondary

MeasureTime frameDescription
Endoscopic findings in descending duodenum5 minutes after intubation of the esophagusAll pathological findings which are seen in descending duodenum should be reported (e.g. ampullary adenoma, peripapillary diverticulum, ampullary carcinoma, inflammatory change of papilla, etc)
Overall endoscopic findings5 minutes after intubation of the esophagusAll pathological findings which are seen during the examination should be reported (e.g. reflux esophagitis, gastric cancer, gastric ulcer, duodenal ulcer, etc)
MDP examination time5 minutes after intubation of the esophagusThe times taken for the examination of the MDP (after passing the pylorus until examination of MDP)
MDP examination score5 minutes after intubation of the esophagusScore 3 when proximal end, distal end and orifice were visualized; Score 2 when either proximal or distal end with orifice were visualized; Score 1 when either proximal or distal end without orifice was visualized; Score 0 when the MDP could not be localized

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026